← TrialMatch
HomeTrials

Missed Opportunities for HIV Screening in General Practice

The number of new HIV diagnoses in France in 2022 is estimated to be between 4,200 and 5,700. Of these diagnoses, 43% of infections were detected at a late stage. The objective of this study is to identify missed opportunities for HIV testing in general practice and to understand the barriers to testing.

Condition(s)HIV Infections
StatusRecruiting
Study typeObservational
SummaryThe number of new HIV diagnoses in France in 2022 is estimated to be between 4,200 and 5,700. Of these diagnoses, 43% of infections were detected at a late stage. The objective of this study is to identify missed opportunities for HIV testing in general practice and to understand the barriers to testing.
Who can participateInclusion Criteria: * Adult subject (≥18 years) * diagnosed with HIV infection between January 1, 2021, and July 30, 2024 Exclusion Criteria: -Subject who arrived in France in the year preceding or during the period between January 1, 2024, and July 30, 2024.
Ages18 Years
SexAll
Lead sponsorUniversity Hospital, Strasbourg, France
LocationsStrasbourg, France
Start date2025-04-14
NCT IDNCT07303114
Official listinghttps://clinicaltrials.gov/study/NCT07303114

🔍 Search all trials →